Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis

J Rheumatol. 2003 Oct;30(10):2207-17.

Abstract

Objective: Chondromodulin-I (ChM-I), a cartilage derived anti-angiogenic factor, has been shown to regulate the vascular invasion during endochondral bone formation. We evaluated the expression and localization of ChM-I in articular cartilage during the progression of osteoarthritis (OA) in the rat, and correlated ChM-I expression with the increase in vascular invasion into OA articular cartilage.

Methods: Expression of ChM-I, type II collagen, basic fibroblast growth factor, vascular endothelial growth factor (VEGF), and matrix metalloproteinases MMP-9 and MMP-13 were examined in articular cartilage of intact growing and adult rats and in the surgically induced OA model using in situ hybridization, Western blot analysis, and immunohistochemistry. Co-immunostaining for ChM-I and CD-31 was performed to localize ChM-I and neovascularization in articular cartilage at advanced stage of OA.

Results: Abundant expression of ChM-I protein was detected in avascular regions of the developing and adult healthy articular cartilage. In early OA, ChM-I expression decreased in the superficial zone of articular cartilage, while levels of proteoglycan and type II collagen were comparable to control. In advanced OA, ChM-I expression was reduced in all zones of articular cartilage, and the number of VEGF-expressing cells was increased. Immunohistochemical studies showed that vascular invasion occurred in proximity to chondrocytes with high expression of pro-angiogenic markers, and decreased expression of ChM-I.

Conclusion: High expression of ChM-I was detected in articular cartilage of growing and normal adult joints, implicating its role in the maintenance of avascularity of intact articular cartilage. Expression of ChM-I decreased, while expression of VEGF and other pro-angiogenic factors increased, in OA cartilage. These findings suggest the loss of ChM-I from articular cartilage might be responsible in part for promoting blood vessel invasion into the cartilage during progression of OA.

MeSH terms

  • Angiogenesis Inhibitors / genetics
  • Angiogenesis Inhibitors / metabolism*
  • Animals
  • Biomarkers / analysis
  • Cartilage, Articular / blood supply
  • Cartilage, Articular / metabolism
  • Cartilage, Articular / pathology*
  • Collagen Type II / metabolism
  • Collagenases / metabolism
  • Disease Models, Animal
  • Hindlimb
  • Immunoenzyme Techniques
  • In Situ Hybridization
  • Intercellular Signaling Peptides and Proteins / genetics
  • Intercellular Signaling Peptides and Proteins / metabolism*
  • Male
  • Matrix Metalloproteinase 13
  • Matrix Metalloproteinase 9 / metabolism
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Neovascularization, Pathologic
  • Osteoarthritis / metabolism
  • Osteoarthritis / pathology*
  • Proteoglycans / metabolism
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Stifle / pathology*
  • Stifle / surgery
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Angiogenesis Inhibitors
  • Biomarkers
  • Cnmd protein, rat
  • Collagen Type II
  • Intercellular Signaling Peptides and Proteins
  • Membrane Proteins
  • Proteoglycans
  • RNA, Messenger
  • Vascular Endothelial Growth Factor A
  • Collagenases
  • Matrix Metalloproteinase 13
  • Mmp13 protein, rat
  • Matrix Metalloproteinase 9